跳至主要内容
临床试验/NCT06733142
NCT06733142已完成不适用

The Effects of a Commercially Available High Protein Spoonable on Amino Acid Bioavailability in 18-45-year-old Male and Female Volunteers.

Glyn Howatson1 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2024年10月9日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
12
试验地点
1
主要终点
Peak Concentration for Total Amino Acids

研究概览

简要总结

The key research objective is to characterise the amino acid (AA) bioavailability for 4 hours following consumption of a single serving of a high protein spoonable yoghurt, compared to a micellar casein drink or a flavoured water-based placebo jelly, in 18-45-year-old males and females. An additional exploratory objective is to characterise the time to reach peak concentration (Tmax) of AA after consumption of a single serving of each product.

详细描述

This study is a single-blind, three-way, randomised crossover design. It involves four visits to the laboratory in total; the first session will be a pre-screening and familiarisation, and the subsequent three sessions will be 3 x bioavailability assessments, separated by a washout period of a minimum of 5 days and maximum of 21 days. The bioavailability assessments will be identical except for the product consumed; subjects will receive one serving of the following in a random order:

  1. Test product: High protein spoonable yoghurt (1 serving = 45 g protein comprising 3 yoghurt pots totalling 480 g) (Danone Nutricia).
  2. Control product 1: Micellar casein drink (1 serving = 45 g protein/480 g).
  3. Control product 2: flavoured water-based placebo jelly (1 serving = 0 g protein comprising 3 jelly pots totalling 480 g).

A follow-up communication via telephone will be conducted within 7 days of completion of the fourth and final session to ensure there are no adverse effects of participation.

A detailed overview of the research activity that will take place in each session is provided below:

Visit 1: Pre-screening: Volunteers will receive information on the study, and they will be familiarised with the requirements for participation and provide written informed consent. Subjects will be requested to complete 3-day food and exercise diaries, comprising of 1 weekend day, 1 rest day, and 1 exercise day within a week of the trial. This will be handed in on Visit 2. Subjects' body height, body mass, body composition, and body mass index (BMI) will be measured.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Single (Participant)

盲法说明

Single-Blinded

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 18 and ≤ 45 years
  • Body Mass Index (BMI) ≥ 18.5 and ≤ 29.9 kg/m2
  • Written informed consent
  • Willingness and ability to comply with the protocol in the opinion of the Investigator
  • Judged by the Investigator to be in good health as assessed by a health screening questionnaire
  • Currently identifies as the same biological sex as at birth

排除标准

  • Any known ongoing medical condition that interferes significantly with absorption and digestion and/or gastrointestinal (GI) function (e.g. inflammatory bowel disease, gastroesophageal reflux disease, celiac disease, diaphragmatic hernia or diaphragmatic surgery, gastric ulcer, gastritis, gall bladder problems, pancreatitis, GI cancer, oesophageal and/or gastric surgery), in opinion of the investigator.
  • Known musculoskeletal or soft tissue injury
  • Known cardiovascular disease, disease related to the immune system and/or the respiratory system
  • Known renal or hepatic failure or known thyroid dysfunction
  • Known Diabetes Mellitus type I or type II, insulin resistance or metabolic syndrome
  • Any ongoing cancer (except for basal cell carcinoma) and/ or cancer treatment
  • Known anaemia or low haemoglobin or low iron status
  • Any known bleeding disorder or reaction to withdrawal of blood samples
  • Use of oral and systemic use of prokinetics, laxatives, antidiarrheals, anticoagulants within 2 weeks prior to screening
  • Use of systemic antibiotics within 4 weeks prior to screening
  • Any known allergies or intolerances to ingredients of the study product, i.e. cow's milk allergies, lactose intolerance
  • Adherence to a strict dietary regime (e.g. vegetarian/ vegan/ paleo/ketogenic/intermittent fasting/ high protein diet (>1.6 g/kg body weight/day) or a weight loss program)
  • Use of any nutritional supplements or additional protein supplements or nutritional support within 4 weeks prior to screening
  • Falling below or exceeding the classification of Tier 1 or Tier 2 (McKay et al 2022, IJSPP. 17, 317-331). Ranging from minimum of meeting WHO guidelines for physical activity up to training ~3 times per week and local level representation in a sport.
  • Known pregnancy and/or lactation
  • Current smoking or stopped smoking for <1 month prior to screening (except for incidental smoking of ≤3 cigarettes/cigars/pipes per week on average in the last month)
  • Average alcohol use of >21 glasses* per week for men or >14 glasses per week for women (on average during the last 6 months) or drug/ medicine abuse in opinion of the investigator
  • Participation in any other clinical study with investigational or marketed products concomitantly or within 4 weeks before screening.
  • Major medical or surgical event requiring hospitalization within the preceding 3 months and/or scheduled in the period of study participation relevant in the opinion of the Investigator

结局指标

主要结局

Peak Concentration for Total Amino Acids

时间窗: At timepoints: T = 0 min (baseline, before consumption) and at t = 15, 30, 45, 60, 90, 120, 150, 180, 210, and 240 min after the study product intake.

Descriptive summary of peak concentration (Cmax) \[µM\] for total AA after consumption of a single serving of a high protein spoonable yoghurt, micellar casein drink, and flavoured water-based placebo jelly in 18-45-year-old males and females over 4 hours.

Incremental Area Under Curve for Total Amino Acids

时间窗: At timepoints: T = 0 min (baseline, before consumption) and at t = 15, 30, 45, 60, 90, 120, 150, 180, 210, and 240 min after the study product intake.

Descriptive summary of incremental area under the curve (iAUC) \[µM\] for total AA after consumption of a single serving of a high protein spoonable yoghurt, micellar casein drink, and flavoured water-based placebo jelly in 18-45-year-old males and females over 4 hours.

次要结局

  • Time to Reach Maximum Concentration of Amino Acids(At timepoints: T = 0 min (baseline, before consumption) and at t = 15, 30, 45, 60, 90, 120, 150, 180, 210, and 240 min after the study product intake.)

研究者

发起方
Glyn Howatson
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Glyn Howatson

Professor

Northumbria University

研究点 (1)

Loading locations...

相似试验

Spoonable Bioavailability | 临床试验